Manipulated data in 17 papers from one cancer research lab in China gets flagged on PubPeer. It ends with the university hospital in Wuhan issuing a secret statement accusing the US pharma giant a Merck of a conspiracy to slander a Chinese Academy member, Dr Ding Ma.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
The 2015 Nature Cell Biology paper by the Spanish cancer researcher Carlos Lopez-Otin and his US partner George Q Daley, stem cell titan and dean of Harvard Medical School, is being retracted. First author and Lopez-Otin’s student Clara Soria-Valles caused Daley even more trouble: her next groundbreaking paper was meant to be already published, but it is not even submitted and might never be.
Too many scientists defend the practice of not probing for loading controls for each protein gel. They say a “library” method perfectly suffices, when one separate loading control gel is run once for reference. Such sloppiness can sometimes be a hint of even worse practices taking place.
Eric Lam is yet another of the many “Curing Cancer with Photoshop” researchers which PubPeer is full of. This professor of molecular Oncology at Imperial College in London is responsible for several papers with duplicated gel bands, but does it matter? He has 250 more.
Two and a half years after Maria Fousteri was found guilty of scientific misconduct by her former employer, the Leiden University Medical Center (LUMC), exactly nothing at all happened. ERC and Molecular Cell ignored LUMC letters from June 2016, while Fouster’s British co-authors interfered to save own papers. Of 4 scheduled retractions, none took place.
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.